Rush J S, Waechter C J
Department of Biochemistry, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Glycobiology. 1998 Dec;8(12):1207-13. doi: 10.1093/glycob/8.12.1207.
In the current model for Glc3Man9GlcNAc2-P-P-Dol assembly, Man5GlcNAc2-P-P-Dol, Man-P-Dol, and Glc-P-Dol are synthesized on the cytoplasmic face of the ER and diffuse transversely to the lumenal leaflet where the synthesis of the lipid-bound precursor oligosaccharide is completed. To establish the topological sites of Glc-P-Dol synthesis and the lipid-mediated glucosyltransfer reactions involved in Glc3Man9GlcNAc2-P-P-Dol synthesis in ER vesicles from pig brain, the trypsin-sensitivity of Glc-P-Dol synthase activity and the Glc-P-Dol:Glc0-2Man9GlcNAc2-P-P-Dol glucosyltransferases (GlcTases) was examined in sealed microsomal vesicles. Since ER vesicles from brain do not contain glucose 6-phosphate (Glc 6-P) phosphatase activity, the latency of the lumenally oriented, processing glucosidase I/II activities was used to assess the intactness of the vesicle preparations. Comparative enzymatic studies with sealed ER vesicles from brain and kidney, a tissue that contains Glc 6-P phosphatase, demonstrate the reliability of using the processing glucosidase activities as latency markers for topological studies with microsomal vesicles from non-gluconeogenic tissues lacking Glc 6-P phosphatase. The results obtained from the trypsin-sensitivity assays with sealed microsomal vesicles from brain are consistent with a topological model in which Glc-P-Dol is synthesized on the cytoplasmic face of the ER, and subsequently utilized by the three Glc-P-Dol-mediated GlcTases after "flip-flopping" to the lumenal monolayer.
在目前的Glc3Man9GlcNAc2-P-P-Dol组装模型中,Man5GlcNAc2-P-P-Dol、Man-P-Dol和Glc-P-Dol在糙面内质网的细胞质面合成,然后横向扩散到腔面膜小叶,在那里完成脂质结合前体寡糖的合成。为了确定Glc-P-Dol合成的拓扑位点以及参与猪脑内质网囊泡中Glc3Man9GlcNAc2-P-P-Dol合成的脂质介导的糖基转移反应,在密封的微粒体囊泡中检测了Glc-P-Dol合成酶活性以及Glc-P-Dol:Glc0-2Man9GlcNAc2-P-P-Dol糖基转移酶(GlcTases)对胰蛋白酶的敏感性。由于脑内质网囊泡不含有葡萄糖6-磷酸(Glc 6-P)磷酸酶活性,因此利用面向腔的加工型葡糖苷酶I/II活性的潜伏性来评估囊泡制剂的完整性。对来自脑和肾(一种含有Glc 6-P磷酸酶的组织)的密封内质网囊泡进行的比较酶学研究表明,对于缺乏Glc 6-P磷酸酶的非糖异生组织来源的微粒体囊泡,使用加工型葡糖苷酶活性作为拓扑研究的潜伏性标记是可靠的。用来自脑的密封微粒体囊泡进行胰蛋白酶敏感性测定得到的结果与一个拓扑模型一致,该模型认为Glc-P-Dol在糙面内质网的细胞质面合成,随后在“翻转”到腔面膜单层后被三种Glc-P-Dol介导的GlcTases利用。